To help improve patient care through better information access, a group of 21 Ontario-based hospitals and facilities are now benefitting from Ontario eHub Health Information Exchange (HIE) powered by Oracle Health. The Ontario eHub can help these healthcare organizations share patient data more easily and securely, reducing administrative overhead, and facilitating improved care coordination for patients. Oracle Health is teaming with TransForm Shared Service Organization to manage the projec

Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered technology and real-world data to help achieve better health outcomes, joins global healthcare company AmerisourceBergen’s Trusted Vendor Program. The collaboration enables community oncology practices, hospitals, and health systems nationwide access to Patient Discovery’s Equitable Care Platform, allowing care providers to proactively identify and address social determinant

The results of the Phase 3 EPITOPE trial of epicutaneous immunotherapy with Viaskin Peanut, sponsored by DBV Technologies, a clinical-stage biopharmaceutical company, were recently published in the New England Journal of Medicine. Dr. Thomas Eiwegger from Karl Landsteiner University of Health Sciences is a co-author on this publication, having participated as a Principal Investigator in this global study. Viaskin is a novel form of EPIT, a potential new class of treatment that harne

Ergéa Group, a prominent platform for cancer care, diagnostic imaging, and medical technology services across Europe, is pleased to announce the appointment of two key positions in its senior team. Brendan Loughran joins Ergéa Group as Head of Supplier Relationships, and Jason Long takes on the role of Head of International projects at Ergéa Group. Both appointments are effective as of May 2023. As Head of Supplier Relationships, Brendan Loughran, an ind

Gaylord Specialty Healthcare, a nonprofit rehabilitation-focused healthcare system, is proud to announce that it is the first healthcare organization in the nation to use the Phagenyx® Neurostimulation System from Phagenesis, Ltd. to treat dysphagia among stroke patients. Dysphagia – or the difficulty or inability to swallow – affects millions worldwide and is a common diagnosis among adult patients at long-term acute care hospitals, including Gaylord Hospital. Dysph

Neuboron Medical Group, a leading global Accelerator-based Boron Neutron Capture Therapy  total solution provider, and Xiamen Humanity Hospital (XHH) collaborated to co-host the Xiamen BNCT Technology Forum 2023 at the BNCT center in XHH. The event agenda underscored various topics, including BNCT clinical research, molecular imaging, nuclear medicine, and the development of next-generation boron drugs. A group of distinguished speakers from renowned research institutions, such as Peking

Juno Pharmaceuticals Canada , a Canadian specialty pharmaceutical company, announced it has received approval from Health Canada to import ketamine solution for injection pursuant to Health Canada’s exceptional importation and sale guidelines. Juno has procured 25,000 units for immediate release, providing a 6-week supply to the entirety of the Canadian market. Health Canada has approved ketamine for use as a sedative and painkiller in hospital settings. As such, it is needed

Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric disorders by transforming psychedelics into effective and licensed medicines, announced today that the first patient has been dosed in its Phase IIa study evaluating BPL-003 as a potential therapy for Treatment Resistant Depression (TRD). BPL-003 is Beckley Psytech’s novel synthetic formulation of the psychedelic compound 5-MeO-DMT (also known as Mebufotenin) and is administered

Startoon Labs Private Limited, a Hyderabad-based ISO 13485:2016 and ISO 9001:2015 Certified medical device R&D, Engineering and Manufacturing Company with a focus on Joint health received US FDA (The US Food and Drug Administration) (510 K Exempt) clearance for its revolutionary wearable device PHEEZEE. The US FDA is a regulatory agency that ensures the safety and security of drugs, devices and other products going into the US Market. Disclosing this in a press note is

Labcorp a leading global life sciences company, today announced an agreement to enter into a strategic relationship with Jefferson Health the largest health system serving the greater Philadelphia area and Southern New Jersey. When complete, the arrangements between Jefferson and Labcorp will serve to build academic collaborations around teaching and the development of innovative tests. The relationship will expand the scope and productivity of specialty lab testing that is retained